Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia

Ting Wanga Department of Hematology, Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, People’s Republic of ChinaView further author information

Haiying Huab Department of Hematology, Wuxi Third people’s hospital, Wuxi, People’s Republic of ChinaView further author information

Zheng Wangc National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, People’s Republic of China;d Suzhou jsuniwell medical laboratory, Suzhou, People’s Republic of ChinaView further author information

Biao Wange Department of Hematology, The Third Affiliated Hospital of Soochow University, Changzhou, People’s Republic of ChinaView further author information

Liujun Caof Department of Hematology, Affiliated Jintan People’s Hospital of Jiangsu University, Changzhou, People’s Republic of ChinaView further author information

Wei Qina Department of Hematology, Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, People’s Republic of ChinaView further author information

Pin Wug Department of Hematology, Wuxi Second people’s hospital, Wuxi, People’s Republic of ChinaView further author information

Xiaohui Caia Department of Hematology, Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, People’s Republic of ChinaView further author information

Hongying Chaoa Department of Hematology, Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information

XuZhang Lua Department of Hematology, Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information

show all

Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date